AIM ImmunoTech closes $8.0M public offering of common stock and warrants

AIM ImmunoTech Inc.

Gross proceeds of $8.0M from offering of 2M shares (or pre-funded warrants) and Class E/F warrants at $4.00 per share.
Class E warrants expire in 5 years, Class F in 18 months; exercise price $4.00 per share.
Maxim Group LLC acted as sole placement agent for the offering.
Offering closed July 31, 2025; registration statement on Form S-1 effective July 28, 2025.

item 1.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.